CITICOLINE IN THE COMPLEX OF EARLY REHABILITATION OF PATIENTS WITH ISCHEMIC STROKE


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The review is devoted to the use of Ceraxon® (citicoline) in a complex of therapeutic and rehabilitation measures in patients with acute ischemic stroke. The results of numerous experimental and clinical studies of the effect of citicoline on ischemia and cerebral hypoxia are presented. The main pharmacological properties of citicoline, which has a complex neuroprotective effect, are described. Data of most recent multicenter placebo-controlled trials of the use of this drug in acute stroke are presented. The basic principles of successful neurorehabilitation in stroke are discussed - early start, continuity, multidisciplinary organizational approach, combination of rehabilitation measures and drug support of neuroplasticity.

Full Text

Restricted Access

About the authors

E. A Petrova

SRI of Cerebrovascular Pathology and Stroke FSBEI HE RNSMU n.a. N.I. Pirogov of RMH; FSBEI HE RNSMU n.a. N.I. Pirogov of RMH

Email: 6332011@mail.ru
Department of Fundamental and Clinical Neurology and Neurosurgery

E. A Koltsova

SRI of Cerebrovascular Pathology and Stroke FSBEI HE RNSMU n.a. N.I. Pirogov of RMH; FSBEI HE RNSMU n.a. N.I. Pirogov of RMH

Department of Fundamental and Clinical Neurology and Neurosurgery

V. V Gudkova

FSBEI HE RNSMU n.a. N.I. Pirogov of RMH

Department of Fundamental and Clinical Neurology and Neurosurgery

L. V Stakhovskaya

SRI of Cerebrovascular Pathology and Stroke FSBEI HE RNSMU n.a. N.I. Pirogov of RMH; FSBEI HE RNSMU n.a. N.I. Pirogov of RMH

Department of Fundamental and Clinical Neurology and Neurosurgery

References

  1. Петрова Е.А., Скворцова В.И., Гудкова В.В. Восстановительная терапия в остром периоде церебрального инсульта. Врач. 2004;6:32-6.
  2. Крыжановский Г.Н. Общая патофизиология нервной системы. М.,1997.
  3. Анохин П.К. Общие принципы компенсации нарушенных функций и их физиологическое обоснование. М.,1977.200 с.
  4. Lo A.C., Guarino, P.D., Richards, L.G., Haselkorn J.K., Wittenberg G.F., Federman D.G., Ringer R.J., Wagner T.H., Krebs H.I., Volpe B.T., Bever C.T. Jr., Bravata D.M., Duncan P.W., Corn B.H., Maffucci A.D., Nadeau S.E., Conroy S.S., Powell J.M., Huang G.D., Peduzzi P. Robotassisted therapy for long-term upper-limb impairment after stroke. N. Engl. J. Med. 2010;362: 1772-83.
  5. Álvarez-Sabín J., Román G.C. The Role of Citicoline in Neuroprotection and Neurorepair in ischemic Stroke. Brain. Sci. 2013;3:1395-414.
  6. Salomon J.A., Wang H., Freeman M.K., Vos T. The global burden of disease study 2010. Lancet. 2013;380:2053-260.
  7. Sahota, P., Savitz S.l. Investigational therapies for ischemic stroke: Neuroprotection and neurorecovery. Neurotherapeutics. 2011;8:434-51.
  8. Zapadnyuk B.V., Kopchak O.O. Features drug correction of vascular cognitive disorders in patients with discirculatory encephalopathy and metabolic. Pro. Neuro. 2010;4:77
  9. Adibhatla R.M., Hatcher J.F. Citicoline mechanisms and clinical efficacy in cerebral ischemia. J. Neurosci. Res. 2002;70:133-39.
  10. Bustamante A., Giralt D., Rosell A., Montaner J., Garcia-Bonilla L., Campos M. Citicoline in preclinical animal models of stroke: A meta-analysis shows the optimal neuroprotective profile and the missing steps for jumping into a stroke clinical trial. J. Neuro-chem. 2012;123:217-25.
  11. Hurtado O., Moro M.A., Cárdenas A., Dávalos A., Sanchez V., Fernández-Tomé P., Leza J.C., Lorenzo P., Secades J.J., Lozano R., Castillo J., Lizasoain I. Neuroprotection afforded by prior citicoline administration in experimental brain ischemia: Effects on glutamate transport. Neurobiol. Dis. 2005;18:336-45.
  12. Saver J.L. Targeting the brain: neuroprotection and neurorestoration in ischemic stroke. Pharmacotherapy. 2010;30:S62.
  13. Xu F., Hongbin H.,Yan J., Lee K., Chen H., He Q., Xu W., Zhu N., Zhang H., Zhou F. Greatly improved neuroprotective efficiency of citicoline by stereotactic delivery in treatment of ischemic injury. Drug. Deliv. 2011;18:461-67.
  14. Hurtado O., Cárdenas A., Pradillo J.M., Morales J.R., Ortego F., Sobrino T., Castillo J., Moro M.A., Lizasoain I. A chronic treatment with CDPcholine improves functional recovery and increases neuronal plasticity after experimental stroke. Neurobiol. Dis. 2007;26:105-11.
  15. Parnetti L., Mignini F., Tomassoni D., Traini E., Amenta F. Cholinergic precursors in the treatment of cognitive impairment of vascular origin: ineffective approaches or need for re-evaluation? J. Neurol. Sci. 2007;257:264-69.
  16. Gutiérrez-Fernández M., Rodriguez-Frutos B., Fuentes B., Vallejo-Cremades M.T., Alvarez-Grech J., Exposito-Alcaide M., Díez-Tejedor E. CDP-choline treatment induces brain plasticity markers expression in experimental animal stroke. Neurochem. Int. 2012;60:310-7. 84.
  17. Diederich K., Frauenknecht K., Minnerup J., Schneider B.K., Schmidt A., Altach E., Eggert V., Sommer C.J., Schäbitz W.R. Citicoline enhances neuroregenerative processes after experimental stroke in rats. Stroke. 2012;43:1931-40.
  18. Krupinski J., Abudawood M., Matou-Nasri S., Al-Baradie R., Petcu E.B., Justicia C., Planas A., Liu D., Rovira N., Grau-Slevin M., Secades J., Slevin M. Citicoline induces angiogenesis improving survival of vascular/human brain microvessel endothelial cells through pathways involving ERK1/2 and insulin receptor substrate-1. Vasc. Cell. 2012;4. doi: 10.1186/2045-824X-4-20.
  19. Krupinski J., Slevin M., Badimon L. Citicoline inhibits MAP kinase signalling pathways after focal cerebral ischaemia. Neurochem. Res. 2005;30:1067-73.
  20. Wang L.E., Fink G.R., Diekhoff S., Rehme A.K., Eickhoff S.B., Grefkes C. Nora-drenergic enhancement improves motor network connectivity in stroke patients. Ann. Neurol. 2011;69:375-88.
  21. Tazaki Y., Sakai F., Otomo E., Kutsuzawa T., Kameyama M., Omae T., Fujishima M., Sakuma A. Treatment of acute cerebral infarction with a choline. 1988;19:211-16.
  22. Клюшников С.А. Нейропротективные и нейрорепаративные эффекты Цераксона (цитиколина): обзор экспериментальных и клинических исследований. Нервные болезни. 2012;3:13-20.
  23. Warach S.J. ECCO 2000 study of citicoline for treatment of acute ischemic stroke: Effects on infarct volumes measured by MRI. Stroke. 2000;31:283.
  24. Dávalos A., Álvarez-Sabín J., Castillo J., Díez-Tejedor E., Ferro J., Martínez-Vila E., Serena J., Segura T., Cruz V.T., Masjuan J., Cobo E., Secades J.J. Citicoline in the treatment of acute ischaemic stroke: An international, randomised, multicentre, placebo-controlled study (ICTUS trial). Lancet. 2012;380:349-57.
  25. Ваизова О.Е., Алифирова В.М., Заутнер Н.А. Клинический опыт применения цитиколина при ишемическом инсульте. Экспер. и клин. фармакол. 2012;3:7.
  26. Гаврилова С.И., Федорова Я.Б., Гантман М.В., Калын Я.Б., Колыхалов И.В. Лечение мягкого когнитивного снижения. Журн. неврологии и психиатрии. 2011;12:16.
  27. Мартынов М.Ю., Ясаманова А.Н., Щукин И.А. Цитопротективная и нейро-трофическая терапия при церебральном инсульте. Клиницист. 2013;7(1):21.
  28. Пирадов М.А. Интенсивная терапия инсульта: взгляд на проблему. Анналы клин. и эксперим. неврологии. 2007;1(1):17-22.
  29. Шамалов Н.А., Стаховская Л.В., Шетова И.М. Ефремова Н.М., Анисимов К.В. Исследование безопасности и эффективности комбинированной терапии цитиколином и Актовегином больных в остром периоде ишемического инсульта. Журн. неврол. и психиатр. им. С.С. Корсакова. 2010;9(2):13-7.
  30. Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack of the European Stroke Organization (ESO) Executive Committee and the ESO Writing Committee, 2008. http:// www.esolstroke.org/pdf/ESO08_Guidelines_ Original_english.pdf.
  31. Álvarez-Sabín J., Ortega G., Jacas C., Santamarina E., Maisterra O., Ribo M., Molina C., Quintana M., Román G.C. Long-term treatment with citicoline may improve post-stroke vascular cognitive impairment. Cerebrovasc. Dis. 2013; 35:146-54.
  32. García-Cobos R., Frank-Garcia A., Gutiérrez-Fernández M., Díez-Tejedor E. Citicoline use in cognitive decline: Vascular and degenerative. J. Neurol. Sci. 2010;299:188-92.
  33. Nam J., Jing H., O'Reilly D. Intra-arterial thrombolysis vs. standard treatment or in-travenous thrombolysis in adults with acute ischemic stroke: A systematic review and meta-analysis. Int. J. Stroke. 2013. doi: 10.1111/j.1747-4949.2012.00914.x.
  34. Скворцова В.И., Гудкова В.В., Иванова Г.Е., Кирильченко Т.Д., Квасова О.В., Апасова Н.Г. Принципы ранней реабилитации больных с инсультом. Инсульт. Приложение к Журн. неврологии и психиатрии. 2002;7:28-33.
  35. Скворцова В.И., Шкловский В.М., Поляев Б.А., Иванова Г.Е., Чекнева Н.С., Гудкова В.В., Петрова Е.А., Волченкова О.В., Шанина Т.В., Борисова Н.В. Основы ранней реабилитации больных с острыми нарушениями мозгового кровообращения. Методич. рекомендации, Министерство здравоохранения и социального развития Российской Федерации. М., 2006. 23 с.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2017 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies